IBM develops macromolecule that could counter antibiotic resistance
Team Udayavani, Jul 23, 2020, 7:11 PM IST
IBM Research team with the support of several other scientists has developed a synthetic macromolecule polymer to counter antibiotic resistance.
It can potentially be used to significantly increase the effectiveness of existing antibiotics. It works by essentially hitching itself to the enzymes that bacteria modify when they are treated using antibiotics, but not completely eliminated
Researchers claim that the polymer attaches to the cytosolic enzymes on the membrane of the pathogens.
However, the report clarified that the study is relatively early research that has been conducted in a highly controlled laboratory.
Researchers worked in partnership with Singapore’s Institute of Bioengineering and Nanotechnology
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Exposure to outdoor artificial light at night may increase risk of stroke, study finds
Group of oncologists launch free-of-cost second opinion helpline number for cancer patients
Dogs understand more than they let on, create mental images of known words: Study
Caution advised as diarrhoea cases rise with onset of summer
Bharat Biotech begins clinical trials of TB vaccine on adults in India
MUST WATCH
Latest Additions
EAM Jaishankar meets Ukranian counterpart Kuleba
CBI clean cheat over Air India-Indian Airlines merger: BJP must apologise to ex-PM Singh, says Raut
Ahead of Lok Sabha polls, I-T department slaps Congress with Rs 1700 cr, demand notice: Report
Kejriwal’s wife launches WhatsApp campaign to garner support for AAP leader
Told to speak softly, man assaults relative; Case filed